| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.065 | 0.05 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.05 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.073 | 0.05 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.062 | 0.06 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.06 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.065 | 0.06 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.23 | 0.06 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.059 | 0.06 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.063 | 0.06 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.067 | 0.06 |